CorMedix Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 0.007636 million compared to USD 0.088261 million a year ago. Net loss was USD 7.03 million compared to USD 7.22 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.2 a year ago.